Mofezolac is a nonsteroidal anti-inflammatory drug (NSAID) mainly marketed in Japan under the brand name Disopain. It functions as a selective COX-1 inhibitor to relieve pain and reduce inflammation. It is typically prescribed to treat osteoarthritis, rheumatoid arthritis, lower back pain, frozen shoulder, and postoperative trauma. It is grouped under the following drug class(es): Cyclooxygenase‑1 (COX‑1) Inhibitors, Cyclooxygenase‑2 (COX‑2) Inhibitors and Non-Steroidal Anti-Inflammatory Drugs (NSAID). The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Mofezolaco and Mofezolacum. Its PubChem CID is 4237.
Mofezolac
| CAS No | 78967-07-4 |
|---|---|
| Molecular Formula | C19H17NO5 |
| Molecular Weight | 339.3 g/mol |
| Synonyms | 2-[3,4-bis(4-methoxyphenyl)-1,2-oxazol-5-yl]acetic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Mofezolac is a nonsteroidal anti-inflammatory drug (NSAID) mainly marketed in Japan under the brand name Disopain. It functions as a selective COX-1 inhibitor to relieve pain and reduce inflammation.
The listed CAS number is 78967-07-4.
The listed molecular formula is C19H17NO5.
The listed molecular weight is 339.3 g/mol.
2-[3,4-bis(4-methoxyphenyl)-1,2-oxazol-5-yl]acetic acid.
The source lists Mofezolaco and Mofezolacum.